Lack of dose dependent kinetics of methyl salicylate-2-O-β-D-lactoside in rhesus monkeys after oral administration.

[1]  Y. Li,et al.  Methyl salicylate lactoside inhibits inflammatory response of fibroblast‐like synoviocytes and joint destruction in collagen‐induced arthritis in mice , 2014, British journal of pharmacology.

[2]  Xiaowei Ma,et al.  Pharmacokinetics of methyl salicylate-2-O-β-D-lactoside, a novel salicylic acid analog isolated from Gaultheria yunnanensis, in dogs. , 2013, Biomedical chromatography : BMC.

[3]  Xiumei Gao,et al.  The pharmacokinetics and oral bioavailability studies of columbianetin in rats after oral and intravenous administration. , 2013, Journal of ethnopharmacology.

[4]  Yang Lv,et al.  Pharmacokinetic study of salvianolic acid A in beagle dog after oral administration by a liquid chromatography-mass spectrometry method: a study on bioavailability and dose proportionality. , 2013, Journal of ethnopharmacology.

[5]  R. Liu,et al.  A novel naturally occurring salicylic acid analogue acts as an anti-inflammatory agent by inhibiting nuclear factor-kappaB activity in RAW264.7 macrophages. , 2012, Molecular pharmaceutics.

[6]  Guanhua Du,et al.  Methyl salicylate 2-O-β-D-lactoside, a novel salicylic acid analogue, acts as an anti-inflammatory agent on microglia and astrocytes , 2011, Journal of Neuroinflammation.

[7]  G. Du,et al.  Synthesis and anti-nociceptive and anti-inflammatory effects of gaultherin and its analogs , 2011, Journal of Asian natural products research.

[8]  G. Du,et al.  Anti-Inflammatory Activity of Methyl Salicylate Glycosides Isolated from Gaultheria yunnanensis (Franch.) Rehder , 2011, Molecules.

[9]  Scott A. Mabury,et al.  Exploring Indirect Sources of Human Exposure to Perfluoroalkyl Carboxylates (PFCAs): Evaluating Uptake, Elimination, and Biotransformation of Polyfluoroalkyl Phosphate Esters (PAPs) in the Rat , 2010, Environmental health perspectives.

[10]  K. Ward,et al.  Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. I. Investigation of potential experimental and mechanistic explanations , 2004, Xenobiotica; the fate of foreign compounds in biological systems.

[11]  K. Ward,et al.  Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. II. Studies implicating transporter-mediated intestinal secretion , 2004, Xenobiotica; the fate of foreign compounds in biological systems.

[12]  G. Shenfield,et al.  Lack of dose dependent kinetics of theophylline , 2004, European Journal of Clinical Pharmacology.

[13]  X. Ma,et al.  [Studies on resources of ethnomedicine Gaultheria leucocarpa var. yunnanensis]. , 2001, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[14]  Thomas M. Ludden,et al.  Nonlinear Pharmacokinetics , 1991, Clinical pharmacokinetics.